BioCardia (BCDA) Receivables - Net (2010 - 2026)

BioCardia (BCDA) has reported Receivables - Net for 15 consecutive years, with $30000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables - Net rose 200.0% year-over-year to $30000.0 in Q2 2026; TTM through Jun 2026 was $30000.0, a 200.0% increase from a year earlier, with the FY2025 full-year figure at $20000.0, changed N/A from the prior year.
• Receivables - Net was $30000.0 for Q2 2026 at BioCardia, up from $20000.0 in the prior quarter.
• Over five years, Receivables - Net peaked at $326000.0 in Q1 2022 and troughed at $10000.0 in Q2 2024.
• A 5-year average of $108733.3 and a median of $63000.0 in 2023 frame the typical range for Receivables - Net.
• Across the five-year window, Receivables - Net slumped 91.3% in 2024 and soared 200.0% in 2026, its largest moves.
• Over 5 years, Receivables - Net stood at $201000.0 in 2022, then slumped by 68.66% to $63000.0 in 2023, then slumped by 84.13% to $10000.0 in 2024, then soared by 100.0% to $20000.0 in 2025, then surged by 50.0% to $30000.0 in 2026.
• The last three Receivables - Net figures came in at $30000.0 (Q2 2026), $20000.0 (Q1 2026), and $20000.0 (Q4 2025), per Business Quant data.